Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions

Hypertrophic cardiomyopathy (HCM) has historically been diagnosed phenotypically. Through genetic testing, identification of a molecular diagnosis (MolDx) is increasingly common but the impact on pediatric patients is unknown. This was a retrospective study of next-generation sequencing data for 602...

Descripción completa

Detalles Bibliográficos
Autores principales: Gal, Dana B., Morales, Ana, Rojahn, Susan, Callis, Tom, Garcia, John, Priest, James R., Truty, Rebecca, Vatta, Matteo, Nussbaum, Robert L., Esplin, Edward D., Hollander, Seth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554517/
https://www.ncbi.nlm.nih.gov/pubmed/34714385
http://dx.doi.org/10.1007/s00246-021-02764-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554517/
https://www.ncbi.nlm.nih.gov/pubmed/34714385
http://dx.doi.org/10.1007/s00246-021-02764-1

Ejemplares similares